AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Vaccine protects cheetah and black rhinoceros against anthrax.

Vaccine Weekly

| December 01, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have developed a vaccine that protects cheetahs and rhinoceroses against anthrax.

According to a study from England, Namibia, and the United States, "Institution of a policy of vaccination in endangered species with a vaccine not previously administered to it cannot be undertaken lightly. This applies even more in the case of cheetah (Acinonyx jubatus) with their unusually monomorphic gene pool and the potential restrictions this places on their immune responses. However, the recently observed mortalities from anthrax in these animals in the Etosha National Park, Namibia, made it imperative to evaluate vaccination. Black rhinoceros (Diceros bicornis), another endangered species in the park, have been vaccinated for over three decades but the effectiveness of this has never been evaluated."

"Passive protection tests in A/J mice using sera from 12 cheetahs together with enzyme immunoassay indicated that cheetah are able to mount seemingly normal primary and secondary humoral immune responses to the Sterne 34F2 live spore livestock vaccine," reported Peter C. B. Turnbull at Arjemptur Technology in England and collaborators in Namibia and the U.S. "Overall protection rates in mice injected with the sera rose and fell in concert with rises and declines in antibody titers, although fine analysis showed that the correlation between titer and protection was complex."

"Once a high level of protection (96% of mice 1 month after a second booster in the cheetahs) had been achieved, the duration of substantial protection appeared good (60% of the mice 5 months after the ...

Related articles from newspapers, magazines, journals, and more
Lock to food-borne pathogen pathway may be key to vaccine.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Medicine and the U.S. Department of Agriculture-Agricultural Research Service. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Antibodies against Neisseria meningitidis isolated.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Neisseria, Bacteriology, Vaccine Development, Immunotherapy, and Meningitis Vaccine. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Vaccines against prion diseases may be in sight.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Neurology, Neuroscience, Vaccine Development, Proteomics, and Emerging Pathogens. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Batch of rabies vaccine found ineffective.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Immunotherapy, Vaccine Development, Vaccine Efficacy, Virology, and Vectors and Zoonoses. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Study shows low risk of vaccinia transfer after immunization.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...hopefully now we've got a lot of contemporary data to help answer it," said Talbot. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
RANK-L gene improves the T cell immune response to infectious agents.
Newspaper article from: Vaccine Weekly February 11, 2004 700+ words
...of DNA Vaccine, Vaccine Development, Vaccine Efficacy, Proteomics, and Virology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Vaccines for cervical cancer reviewed.
Newspaper article from: Vaccine Weekly February 11, 2004 700+ words
...Oncology, Immunotherapy, Virology, Vaccine Development, and Women's Health. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Thailand rejects criticism of AIDS vaccine trial.
Newspaper article from: Vaccine Weekly February 11, 2004 700+ words
...elaborate experiments are needed to prove whether the combination is effective, they said. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
For more facts and information, see all results

Source: HighBeam Research, Vaccine protects cheetah and black rhinoceros against anthrax.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA